Click here to view the original post by Healio Ophthalmology.
In addition to our own original articles, the Retina Consultant team expertly curates relevant news and research from leading publications.to provide our readers with a comprehensive view of the retina & ophthalmology landscape, Full credit belongs to the original authors and publication.
By clicking the link above, you will be leaving our site to view an article from its original source.
Sharpen your perspective. Get our weekly analysis of the news shaping the retina industry.
In an ongoing phase 1 clinical trial, a patient who was recognized as legally blind was implanted with a 3D bioprinted corneal implant.
According to a press release from Precise Bio, the implant, known as PB-001, is manufactured using a robotic 3D biofabrication system, with the aim of improving visual outcomes, lowering complication rates and providing a solution for the global corneal tissue shortage. The implantation of PB-001 marked the world’s first transplant of a cell-based, functional 3D bioprinted cornea, the release said.
“This achievement marks a turning point for regenerative